U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H7NO2
Molecular Weight 137.136
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANTHRANILIC ACID

SMILES

NC1=C(C=CC=C1)C(O)=O

InChI

InChIKey=RWZYAGGXGHYGMB-UHFFFAOYSA-N
InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10)

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including: DOI: 10.2174/157017906777934926 | https://www.ncbi.nlm.nih.gov/pubmed/12844171

Sodium anthranilate is an excipient (pharmacologically inactive substance). Sodium anthranilate (Aminobenzoate sodium ,C7H6NNaO2), also known as sodium 2-aminobenzoate, is an organic amine. Aminobenzoate sodium exists as a yellow powder for use in pharmaceutical processing.

Originator

Sources: DOI: 10.2174/157017906777934926

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
Desoxyn

Approved Use

Desoxyn is used in the treatment of adhd; obesity and belongs to the drug classes anorexiants, CNS stimulants.

Launch Date

1943
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
2001
Electrophoretic sequencing of heparin/heparan sulfate oligosaccharides using a highly sensitive fluorescent end label.
2001 Feb
Enhanced biodegradation of petrochemical wastewater using ozonation and BAC advanced treatment system.
2001 Mar
Effects of the butylated hydroxyanisole and butylated hydroxytoluene on the DNA adduct formation and arylamines N-acetyltransferase activity in human colon tumor cells.
2001 Mar-Apr
Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11).
2001 May 15
[Oxidation of indole and its derivatives by heme-independent chloroperoxidases].
2001 May-Jun
Report of 19 cases of photoallergic contact dermatitis to sunscreens seen at the Skin and Cancer Foundation.
2001 Nov
Functionalized oligoanthranilamides: modular and conformationally controlled scaffolds.
2001 Sep
Phenazine biosynthesis in Pseudomonas fluorescens: branchpoint from the primary shikimate biosynthetic pathway and role of phenazine-1,6-dicarboxylic acid.
2001 Sep 26
Monitoring glycosylation of therapeutic glycoproteins for consistency using highly fluorescent anthranilic acid.
2002
Photocyclization of N,N-phthaloylanthranilic amides coupled to omega-amino acids with increasing chain lengths.
2002 Apr
Location of abasic sites in oligodeoxynucleotides by tandem mass spectrometry and by a chemical cleavage initiated by an unusual reaction of the ODN with MALDI matrix.
2002 Dec
Induction of anthranilate synthase activity by elicitors in oats.
2002 Jan-Feb
Role of rhizobial biosynthetic pathways of amino acids, nucleotide bases and vitamins in symbiosis.
2002 Jul
Modification of carbon nanofibres for the immobilization of metal complexes: a case study with rhodium and anthranilic acid.
2002 Jul 2
[Structural variation of o-amino-benzoic acid induced by free electron laser].
2002 Jun
The catalytic mechanism of indole-3-glycerol phosphate synthase: crystal structures of complexes of the enzyme from Sulfolobus solfataricus with substrate analogue, substrate, and product.
2002 Jun 7
Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
2002 Mar
Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides.
2002 Nov 15
Yeast D-amino acid oxidase: structural basis of its catalytic properties.
2002 Nov 29
Allergic contact dermatitis from etofenamate without cross-sensitization to other anthranilic acid derivatives.
2003
Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity.
2003 Aug 1
S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.
2003 Aug 1
Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
2003 Feb 10
High-performance liquid chromatography assay for 1-deoxy-D-xylulose 5-phosphate synthase activity using fluorescence detection.
2003 Feb 7
Kynurenines and the respiratory parameters on rat heart mitochondria.
2003 Jan 24
Peptides to peptidomimetics: towards the design and synthesis of bioavailable inhibitors of oligosaccharyl transferase.
2003 Jan 7
Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.
2003 Jul 1
Gene cluster of Arthrobacter ilicis Ru61a involved in the degradation of quinaldine to anthranilate: characterization and functional expression of the quinaldine 4-oxidase qoxLMS genes.
2003 Jul 25
A quasi-tetrahedral Cu4 cluster and a helical-chain copper (II) complex with single syn-anti carboxylate bridges: crystal structure and magnetic properties.
2003 Jun 30
Conjugate additions of o-iodoanilines and methyl anthranilates to acetylenic sulfones. A new route to quinolones including first syntheses of two alkaloids from the medicinal herb Ruta chalepensis.
2003 Mar 21
Complexity of coordinative bonding in thallium(I) anthranilates and salicylates.
2003 Mar 26
Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
2003 May 1
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs.
2003 May 19
Probing cathepsin K activity with a selective substrate spanning its active site.
2003 Oct 15
A concise total synthesis of (+/-)-alantrypinone by a novel hetero-Diels-Alder reaction.
2003 Sep 4
Waste-free and facile solid-state protection of diamines, anthranilic acid, diols, and polyols with phenylboronic acid.
2003 Sep 5
Production and analysis of organic acids in hairy-root cultures of Isatis indigotica Fort. (indigo woad).
2004 Feb
Patents

Sample Use Guides

15,000 or 30,000 ppm for the rats, and either 25,000 or 50,000 ppm for the mice, 5 days per week for 78 weeks
Route of Administration: Oral
The DNA damage effects of tryptophan metabolites were analyzed using plasmid relaxation assay performed with anthranilic acid at various concentrations between 50 uM and 400 uM in the presence of plasmid DNA pSP-72. Anthranilic acid did not show any plasmid relaxation activity.
Name Type Language
ANTHRANILIC ACID
HSDB   WHO-DD  
Systematic Name English
NSC-40929
Code English
Anthranilic acid [WHO-DD]
Common Name English
NSC-144
Code English
VITAMIN L1
Common Name English
O-AMINOBENZOIC ACID
MI  
Systematic Name English
NCI-C01730
Code English
ANTHRANILIC ACID [HSDB]
Common Name English
BENZOIC ACID, 2-AMINO-
Common Name English
2-AMINOBENZOIC ACID
Systematic Name English
O-CARBOXYANILINE
Common Name English
BENZOIC ACID, O-AMINO-
Common Name English
ANTHRANILIC ACID [IARC]
Common Name English
O-ANTHRANILIC ACID
Common Name English
O-AMINOBENZOIC ACID [MI]
Common Name English
1-AMINO-2-CARBOXYBENZENE
Systematic Name English
2-CARBOXYANILINE
Systematic Name English
Classification Tree Code System Code
DEA NO. 8530
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
Code System Code Type Description
MESH
C031385
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
SMS_ID
100000077403
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
HSDB
1321
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
CHEBI
30754
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
FDA UNII
0YS975XI6W
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
CAS
118-92-3
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
PUBCHEM
227
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
EVMPD
SUB12908MIG
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
NSC
144
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
EPA CompTox
DTXSID8020094
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
WIKIPEDIA
ANTHRANILIC ACID
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
NSC
40929
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
MERCK INDEX
m1687
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
204-287-5
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY
DRUG BANK
DB04166
Created by admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
PRIMARY